McKesson Price to Sales Ratio 2010-2024 | MCK

Historical PS ratio values for McKesson (MCK) over the last 10 years. The current P/S ratio for McKesson as of June 14, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
McKesson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-06-14 589.95 0.26
2024-03-31 536.85 $2,294.35 0.23
2023-12-31 462.43 $2,209.56 0.21
2023-09-30 434.33 $2,102.60 0.21
2023-06-30 426.16 $2,016.66 0.21
2023-03-31 354.60 $1,931.67 0.18
2022-12-31 373.02 $1,876.02 0.20
2022-09-30 337.49 $1,828.69 0.18
2022-06-30 323.45 $1,769.15 0.18
2022-03-31 303.11 $1,677.13 0.18
2021-12-31 245.69 $1,640.64 0.15
2021-09-30 196.65 $1,560.64 0.13
2021-03-31 191.09 $1,474.50 0.13
2020-12-31 169.99 $1,428.57 0.12
2020-09-30 145.22 $1,432.52 0.10
2020-06-30 149.19 $1,389.20 0.11
2020-03-31 131.19 $1,362.87 0.10
2021-06-30 188.19 $1,335.40 0.14
2019-12-31 133.77 $1,204.71 0.11
2019-09-30 131.79 $1,163.68 0.11
2019-06-30 129.22 $1,115.54 0.12
2019-03-31 112.20 $1,081.12 0.10
2018-12-31 105.56 $1,062.41 0.10
2018-09-30 126.35 $1,031.94 0.12
2018-06-30 126.68 $1,013.14 0.13
2018-03-31 133.46 $992.38 0.13
2017-12-31 147.41 $963.80 0.15
2017-09-30 144.86 $931.84 0.16
2017-06-30 154.81 $903.04 0.17
2017-03-31 139.26 $881.49 0.16
2016-12-31 131.68 $863.38 0.15
2016-09-30 156.03 $844.03 0.18
2016-06-30 174.38 $832.42 0.21
2016-03-31 146.70 $816.61 0.18
2015-12-31 183.67 $807.45 0.23
2015-09-30 172.05 $797.95 0.22
2015-06-30 208.75 $778.37 0.27
2015-03-31 209.83 $761.06 0.28
2014-12-31 192.35 $732.25 0.26
2014-09-30 180.18 $682.02 0.26
2014-06-30 172.14 $635.67 0.27
2014-03-31 163.02 $589.63 0.28
2013-12-31 148.81 $555.48 0.27
2013-09-30 118.12 $538.32 0.22
2013-06-30 105.21 $520.73 0.20
2013-03-31 99.02 $509.68 0.19
2012-12-31 88.76 $506.12 0.18
2012-09-30 78.59 $499.40 0.16
2012-06-30 85.45 $496.29 0.17
2012-03-31 79.81 $486.41 0.16
2011-12-31 70.68 $471.47 0.15
2011-09-30 65.78 $458.09 0.14
2011-06-30 75.50 $442.31 0.17
2011-03-31 71.18 $425.20 0.17
2010-12-31 63.23 $413.09 0.15
2010-09-30 55.35 $406.79 0.14
2010-06-30 59.98 $401.81 0.15
2010-03-31 58.54 $398.89 0.15
2009-12-31 55.56 $395.29 0.14
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $76.685B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $24.405B 13.96
West Pharmaceutical Services (WST) United States $24.275B 43.51
Align Technology (ALGN) United States $19.273B 37.21
Cooper (COO) United States $18.612B 27.45
Labcorp (LH) United States $16.850B 14.51
Henry Schein (HSIC) United States $8.426B 14.99
DENTSPLY SIRONA (XRAY) United States $5.421B 14.04
Merit Medical Systems (MMSI) United States $4.753B 26.05
CONMED (CNMD) United States $2.190B 19.86
Patterson (PDCO) United States $2.027B 9.71
STAAR Surgical (STAA) United States $2.025B 77.77
Atrion (ATRI) United States $0.794B 42.40
Lifevantage (LFVN) United States $0.088B 11.31
Pro-Dex (PDEX) United States $0.066B 33.31
Biolase (BIOL) United States $0.005B 0.00